Healthcare innovation is not for the faint of heart. Beyond developing the science and the tech, health entrepreneurs face a notoriously difficult path to profit.
It’s not just about securing capital. Depending on the sector – whether digital health, diagnostics, medical device, biotech or healthcare services – the journey involves conducting expensive laboratory testing with animals followed by clinical trials in humans, navigating multi-jurisdictional regulations for drug and device approvals or care delivery, deciphering reimbursement pathways, and convincing large, conservative hospital systems and insurance companies to take a bet on a new product or service.
And this is why, perhaps more than any other industry, health startups need established ecosystems of support – the kind fostered by incubators and accelerators.
Science Center Capital Readiness Program – Philadelphia, PA
Interviewed: Tiara Durham, Director of Commercialization Programming; Kristen Fitch, Senior Director of Marketing
Philadelphia’s University City Science Center, an independent nonprofit founded in 1963, builds programs to fill gaps in the innovation ecosystem, and capital readiness is one of them. Launched in 2023, its Capital Readiness Program serves medtech, diagnostics and digital health companies that are commercializing in the U.S., have raised at least $500,000 and are preparing for a first institutional round.
Three times a year, a cohort of 10 companies spends a tightly compressed week in Philadelphia with five active investors in residence, plus legal, accounting, payer, provider and health-system experts. The work covers corporate housekeeping, due diligence, data rooms, regulatory pathways, financial readiness and deal terms, with homework the night before and scenarios designed to stress-test each company. The program doesn’t focus on pitching, and there’s no demo day. What sets it apart is the investors’ commitment: a full week with the founders rather than a speed-networking slot. About 36 investors have taken part since 2023, and while they aren’t there to invest, some have.
The program’s more than 109 alumni companies have raised over $170 million, and the Science Center tracks those that have moved headquarters, run pilots or found customers in Philadelphia.
Economics: No investment, equity or fees; founders cover their own travel and lodging.
